Open Label Study of R788 in the Treatment of Persistent/Chronic Immune

See also
Status	Clinical Trial	Phase
Recruiting	`NCT01255332` - Helicobacter Pylori Immune Thrombocytopenic Purpura	Phase 2
Completed	`NCT01719692` - Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia	N/A
Completed	`NCT01621204` - A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia Patients	Phase 3
Completed	`NCT01730352` - Helicobacter Pylori Treatment in Immune Thrombocytopenic Purpura (ITP) Patients	Phase 2/Phase 3
Completed	`NCT01713855` - Vaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura	N/A
Not yet recruiting	`NCT05093257` - Study of T Cells and Natural Killer Cells Expression in Patients With Immune Thrombocytopenic Purpura
Completed	`NCT01390649` - A Safety Study of Intravenous Immunoglobulin in Patients With Chronic Immune Thrombocytopenic Purpura (ITP)	Phase 4
Completed	`NCT01672151` - Efficacy of Rapamycin Therapy With Chronic Immune Thrombocytopenia	N/A
Completed	`NCT01439321` - Outcomes Comparison of Chronic Immune Thrombocytopenic Purpura (ITP) Patients Switched to Eltrombopag and Romiplostim	N/A
Completed	`NCT00774202` - Higher Dose of Rituxan Versus Standard Doses of Rituxan With Cyclophosphamide, Vincristine, and Prednisone in Subjects With Chronic ITP	Phase 2/Phase 3
Completed	`NCT02273960` - Study to Evaluate Safety and Efficacy in Adult Subjects With ITP	Phase 1/Phase 2
Not yet recruiting	`NCT05585944` - " Effect of Single-nucleotide Polymorphism of CD40 Gene rs1883832 C/T on the Risk of Immune Thrombocytopenic Purpura "	N/A
Recruiting	`NCT03177629` - H. Pylori Eradication for Moderate ITP	Phase 3
Not yet recruiting	`NCT05835050` - Assessment of Serum interleukin10 Level in Patients With Immune Thrombocytopenic Purpura at Sohag University Hospital	N/A
Active, not recruiting	`NCT03395210` - A Study of Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP)	Phase 2
Completed	`NCT00621894` - Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation	Phase 2
Not yet recruiting	`NCT06444477` - Molecular Analysis of Thrombocytopenia and Cancer (MATAC): Investigating Antigenic Mimicry Between Platelets and Tumor Cells in Patients With Immune Thrombocytopenia (ITP) Associated With Cancer
Completed	`NCT01652599` - Eltrombopag and High-dose Dexamethasone as First Line Treatment for IT	Phase 2
Completed	`NCT00426270` - Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in Adults	Phase 3
Completed	`NCT02085993` - Study of Patients With ITP Estimating the Proportion Administering Romiplostim Correctly After Receiving Home Administration Training	N/A

NCT number	NCT02077192
Study type	Interventional
Source	Rigel Pharmaceuticals
Contact
Status	Completed
Phase	Phase 3
Start date	October 2014
Completion date	June 2, 2020

Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms